<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35260380</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2254-8874</ISSN><JournalIssue CitedMedium="Internet"><Volume>222</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Revista clinica espanola</Title><ISOAbbreviation>Rev Clin Esp (Barc)</ISOAbbreviation></Journal><ArticleTitle>Persistent COVID-19 syndrome. A narrative review.</ArticleTitle><Pagination><StartPage>241</StartPage><EndPage>250</EndPage><MedlinePgn>241-250</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rceng.2021.10.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2254-8874(22)00008-X</ELocationID><Abstract><AbstractText>As the coronavirus-2019 disease (COVID-19) pandemic, caused by the infection with severe acute respiratory syndrome (SARS-CoV-2) coronavirus type 2, has progressed, persistent COVID-19 syndrome is an increasingly recognized problem on which a significant volume of medical literature is developing. Symptoms may be persistent or appear, after an asymptomatic period, weeks or months after the initial infection. The clinical picture is as markedly heterogeneous and multisystemic as in the acute phase, so multidisciplinary management is required. In addition, their appearance is not related to the severity of the initial infection, so they can affect both mild patients, even asymptomatic, and seriously ill patients who have required hospitalization. Although it can affect people of any age, it is more common in middle-aged women. The sequelae can generate a high impact on the quality of life, and in the work and social environment. The objective of this paper is to review persistent COVID-19 syndrome, to know its clinical manifestations and the strategies for the management and follow-up of these patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Espa&#xf1;a, S.L.U. and Sociedad Espa&#xf1;ola de Medicina Interna (SEMI). All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xf3;pez-Sampalo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Regional Universitario de M&#xe1;laga, Instituto de Investigaci&#xf3;n Biom&#xe9;dica de M&#xe1;laga (IBIMA), Universidad de M&#xe1;laga (UMA), M&#xe1;laga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernal-L&#xf3;pez</LastName><ForeName>M R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Regional Universitario de M&#xe1;laga, Instituto de Investigaci&#xf3;n Biom&#xe9;dica de M&#xe1;laga (IBIMA), Universidad de M&#xe1;laga (UMA), M&#xe1;laga, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red Fisiopatolog&#xed;a de la Obesidad y Nutrici&#xf3;n (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: rosa.bernal@ibima.eu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Huelgas</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Regional Universitario de M&#xe1;laga, Instituto de Investigaci&#xf3;n Biom&#xe9;dica de M&#xe1;laga (IBIMA), Universidad de M&#xe1;laga (UMA), M&#xe1;laga, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red Fisiopatolog&#xed;a de la Obesidad y Nutrici&#xf3;n (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Clin Esp (Barc)</MedlineTA><NlmUniqueID>101632437</NlmUniqueID><ISSNLinking>2254-8874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>A medida que ha avanzado la pandemia de la enfermedad por coronavirus 2019 (COVID-19), originada por la infecci&#xf3;n por el coronavirus de tipo 2, causante del s&#xed;ndrome respiratorio agudo severo (SARS-CoV-2), el s&#xed;ndrome de COVID-19 persistente es un problema cada vez m&#xe1;s reconocido y sobre el que se est&#xe1; desarrollando un importante volumen de publicaciones. Los s&#xed;ntomas pueden ser persistentes o aparecer, tras un periodo asintom&#xe1;tico, semanas o meses despu&#xe9;s de la infecci&#xf3;n inicial. El cuadro cl&#xed;nico es tan marcadamente heterog&#xe9;neo y multisist&#xe9;mico como en la fase aguda, por lo que se requiere un manejo multidisciplinar. Adem&#xe1;s, su aparici&#xf3;n no est&#xe1; relacionada con la gravedad de la infecci&#xf3;n inicial, por lo que pueden afectar tanto a pacientes leves, incluso asintom&#xe1;ticos, como a enfermos graves que han requerido hospitalizaci&#xf3;n. Aunque puede afectar a personas de cualquier edad, es m&#xe1;s frecuente en mujeres de edad media. Las secuelas pueden generar un elevado impacto en la calidad de vida, y en el &#xe1;mbito laboral y social. El objetivo de este trabajo es hacer una revisi&#xf3;n sobre el s&#xed;ndrome de COVID-19 persistente, conocer sus manifestaciones cl&#xed;nicas y las estrategias para el manejo y seguimiento de estos pacientes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Espa&#xf1;a, S.L.U. and Sociedad Espa&#xf1;ola de Medicina Interna (SEMI). All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID de larga duraci&#xf3;n</Keyword><Keyword MajorTopicYN="N">COVID-19 persistente</Keyword><Keyword MajorTopicYN="N">COVID-19 posagudo</Keyword><Keyword MajorTopicYN="N">COVID-19 sequels</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Persistent COVID-19</Keyword><Keyword MajorTopicYN="N">Post-acute COVID</Keyword><Keyword MajorTopicYN="N">Secuelas COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35260380</ArticleId><ArticleId IdType="pmc">PMC8882405</ArticleId><ArticleId IdType="doi">10.1016/j.rceng.2021.10.001</ArticleId><ArticleId IdType="pii">S2254-8874(22)00008-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahase E. Covid-19: what do we know about &#x201c;long covid&#x201d;? BMJ. 2020;370:m2815.</Citation><ArticleIdList><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun [Internet] 2020;109</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127067</ArticleId><ArticleId IdType="pubmed">32113704</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Rojo J.M., Ant&#xf3;n-Santos J.M., Mill&#xe1;n-N&#xfa;&#xf1;ez-Cort&#xe9;s J., Lumbreras-Bermejo C., Ramos-Rinc&#xf3;n J.M., Roy-Vallejo E., et al. en nombre del Grupo SEMI-COVID-19 Network. [Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry] Rev Clin Esp (Barc) 2020;220:480&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480740</ArticleId><ArticleId IdType="pubmed">32762922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Place S., Van Laethem Y., Cabaraux P., Mat Q., et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Interno Med. 2020;288:335&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267446</ArticleId><ArticleId IdType="pubmed">32352202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P., Cuapio A. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11 doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T., Crewther S. Post-COVID 19 neurological syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neur Sci. 2020;419</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550857</ArticleId><ArticleId IdType="pubmed">33070003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando H.M., Bennett T.D., Byard J.B., Bramante C., Callahan T., Chute G.C., et al. Challenges in defining Long COVID: striking differences across literature, Electronic Health Records, and patient-reported information [preprint] MedRxiv. 2021 doi: 10.1101/2021.03.20.21253896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made long Covid. Soc Sci Med. 2021;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Emergency use ICD codes for COVID-19 disease outbreak [Internet] 2021. https://www.who.int/standars/classifications/classification-of-diseases/emergency-use-icd-codes-for-covid19-disease-outbreak [Accessed 10 January 2021]. Available from:</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) 2021. COVID-19 rapid guideline: managing the long-term effects of COVID-19) March 23 [Accessed 10 January 2021]. Available from: Overview | COVID-19 rapid guideline: managing COVID-19 | Guidance | NICE.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociedad Espa&#xf1;ola de M&#xe9;dicos Generales y de Familia (SEMG) Gu&#xed;a cl&#xed;nica para el paciente Long COVID/COVID. 2021. https://www.semg.es/index.php/consensos-guias-y-protocolos/363-guia-clinica-para-la-atencion-al-paciente-long-covid-covid-persistente [Accessed 23 December 2021]. Available from:</Citation></Reference><Reference><Citation>Lled&#xf3; G., Sellares J., Brotons C., Sans M., D&#xed;ez J., Blanco J., et al.  Post-Acute COVID Syndrome (PACS): Definition, Impact and Management. A Report of the Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19. 2021. http://hdl.handle.net/2445/178471 ISGlobal, CoMB. [Accessed 23 December 2021]. Available from:</Citation></Reference><Reference><Citation>White P.D., Thomas J.M., Kangro H.O. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet. 2001;358:1946&#x2013;1954.</Citation><ArticleIdList><ArticleId IdType="pubmed">11747919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Ancochea J. On the new post Covid condition. Arch Bronconeumol (Engl Ed) 2021;57:735&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8051002</ArticleId><ArticleId IdType="pubmed">33958231</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney O.J., Mc Evoy N.L., McElvaney O.F., Carrol T.P., Murphy M.P., Dunlea D.M., et al. Characterization of the inflammatory response to severe COVID-19 Illness. Am J Respir Crit Care Med. 2020;202:812&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrandi P.J., Always S.E., Mohamed J.S. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol. 2020;129:864&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832004</ArticleId><ArticleId IdType="pubmed">32673162</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C., Muescksch F., Shlomo F., Tokuyama M., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Tianyang M., Klein J., Dai Y., Huck D., Liu J.F., et al. Diverse functional autoantibodies in Patients with COVID-19. Nature. 2021;595:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors J.M., Levy J.H. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033&#x2013;2040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S. The expanded autonomic system, dyshomeostasis and COVID-19. Clin Auton Res. 2020;30:299&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7374073</ArticleId><ArticleId IdType="pubmed">32700055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Wang A., Liu M., Wang Q., Chen J., Xia S., et al.  Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. 2020. https://www.medrxiv.org/content/medrxiv/early/2020/04/06/2020.03.30.20047365.full.pdf [Accessed 23 December 2021]. Available from:</Citation></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Expanding our understanding of post COVID-19 condition. Report of a WHO webinar, 9 February. 2021. https://www.who.int/publications/i/item/978924002503527 [23 Dic 2021]. Available from:</Citation></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., et al. Attributes and pre-dictors of Long-COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174:576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Xiaoying G., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte A., Rivera-Izquierdo M., Guerrero-Fern&#xe1;ndez de Alba I., P&#xe9;rez-Contreras M., Fern&#xe1;ndez-Mart&#xed;nez N.F., Ruiz-Montero R., et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Ledo P., Armenteros del Olmo L., Guerrero-Caballero S., Bilbao-Fern&#xe1;ndez S., en representaci&#xf3;n de Sociedad Espa&#xf1;ola de M&#xe9;dicos Generales y de Familia (SEMG) y colectivo Long COVID ATS La persistencia de s&#xed;ntomas de la COVID-19 y su diagn&#xf3;stico en la primera ola de la pandemia en Espa&#xf1;a. Med Gen Fam. 2021;10:53&#x2013;59.</Citation></Reference><Reference><Citation>Rubio-Rivas M., Corbella X., Mora-Luj&#xe1;n J.M., Loureiro-Amigo J., L&#xf3;pez Sampalo A., Yera Bergua C., et al. Predicting clinical outcome with phenotypic clusters in COVID-19 pneumonia: an analysis of 12,066 hospitalized patients from the Spanish Registry SEMI-COVID-19. J Clin Med. 2020;9:3488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693215</ArticleId><ArticleId IdType="pubmed">33137919</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., et al. Post-COVID syndrome non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Heart. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: &#xbf;the post-COVID-19 syndrome? ERJ Open Res. 2020;6 00542&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmed L. Managing the long-term effects of Covid-19: summary of NICE, SIGN and RCGP rapid guideline. BMJ. 2020;372:m136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S. The possible association between COVID-19 and postural tachycardia syndrome. Hear Rhythm. 2021;18:508&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., Mclvor C., Whyatt G., Adams A., Harvey O., McLean L., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wang X., Zhang S., Lin B., Wu X., Wang Y. Characteristics of acute pulmonary embolism in patients with COVID-19 associated pneumonia from the city of Wuhan. Clin Appl Throm Hemost. 2020;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391435</ArticleId><ArticleId IdType="pubmed">32726134</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Capit&#xe1;n C., Barba R., D&#xed;az-Pedroche M.C., Sig&#xfc;enza P., Demelo-Rodriguez P., Siniscalchi C., et al. Presenting characteristics, treatment patterns, and outcomes among patients with venous thromboembolism during hospitalization for COVID-19. Semin Thromb Hemost. 2021;47:351&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">33086403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J., Hong J., Pinggui L., Bing F., Yingying Q., Pinggui L., et al. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J Xray Sci Technol [Internet] 2020;28:383&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7369060</ArticleId><ArticleId IdType="pubmed">32474479</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M., Liu Y., Xu D., Zhang R., Lan L., Xu H. Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after tTreatment for COVID-19 pneumonia. Korean J Radiol. 2020;21:746&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231610</ArticleId><ArticleId IdType="pubmed">32410413</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Molina M. Sequels and consequences of COVID-19. Med Respir. 2020;13:71&#x2013;77. http://www.neumologiaysalud.es/descargas/R13/R132-8.pdf [Accessed 23 December 2021]. Available from:</Citation></Reference><Reference><Citation>Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;24:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik I.J., Tyler K.L. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Golenbock D., Latz E., Morgan D., Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Thie E., Arca K.N., Starling A.J. Treatment-refractory headache in the setting of COVID-19 pneumonia: migraine or meningoencephalitis? Case report. SN Compr Clin Med. 2020;2:1200&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314569</ArticleId><ArticleId IdType="pubmed">32838146</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F., Milne A., Morley A.J., Viner J., Attwood, et al. Patient outcomes after hospitalization with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Ho L.P., Kalimuddin S., Cherng B.P.Z., Teh Y.E., Thien S.Y., et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) Nutrition. 2020;79&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832811</ArticleId><ArticleId IdType="pubmed">33039952</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwanwongse K., Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID&#x2010;19: causality or coincidence? A report of three cases. J Med Virol. 2021;93:1150&#x2013;1153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404645</ArticleId><ArticleId IdType="pubmed">32706395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Kapoor N., Cao Y., Tapp R.J., Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Med (Internet) 2021;23:870&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee L., Hajanto S., Rosario B.H. COVID-19 complicated by Hashimoto&#x2019;s thyroiditis. Singapore Med J. 2021;62:265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801861</ArticleId><ArticleId IdType="pubmed">32668831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu-Salat M., Urgell E., Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves&#x2019; disease after COVID-19. J Endocrinol Invest. 2020;43:1527&#x2013;1528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7368923</ArticleId><ArticleId IdType="pubmed">32686042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri R.M., Campenni A., Siracusa M., Frazzetto G., Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19. Hormones (Athens) 2020;20:219&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365600</ArticleId><ArticleId IdType="pubmed">32676935</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:4&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Postolache T.T., Benros M.E., Brenner L.A. Targetable biological mechanisms implicated in emergent psychiatric conditions associated with SARS-CoV-2 infection. JAMA Psychiatry. 2021;78:353&#x2013;354. doi: 10.1001/jamapsychiatry.2020.2795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.2795</ArticleId><ArticleId IdType="pubmed">32735332</ArticleId></ArticleIdList></Reference><Reference><Citation>Barquilla A., Gamir Ruiz F.J., Garc&#xed;a Matar&#xed;n L. Sociedad Espa&#xf1;ola de M&#xe9;dicos de Atenci&#xf3;n Primaria (SEMERGEN); 2020. Protocolo de actuaci&#xf3;n en pacientes con COVID-19 asistidos en atenci&#xf3;n primaria. https://www.semergen.es/files/docs/COVID-19/Documentos/monografia_COVID-19_v3_13-10-20.pdf [Accessed 23 December 2021]. Available from:</Citation></Reference><Reference><Citation>Barquilla Garc&#xed;a A., Del Corral E., Diaz Pedroche C., Lumbreras Bermejo C., Mart&#xed;n Sanchez V., Mor&#xe1;n Bay&#xf3;n A., et al.  Sociedad Espa&#xf1;ola de Medicina Interna (SEMI). Sociedad Espa&#xf1;ola de M&#xe9;dicos de Atenci&#xf3;n Primaria (SEMERGEN); 2020. Protocolo para la continuidad asistencial del paciente con diagn&#xf3;stico de COVID-19. https://www.fesemi.org/sites/default/files/documentos/776.pdf [Accessed 23 December 2021]. Available from:</Citation></Reference><Reference><Citation>British Thoracic Society guidance on respiratory follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia. Brithish Thoracic Society; 2020. https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/resp-follow-up-guidance-post-covid-pneumonia/ [Accessed 23 December 2021]. Available from:</Citation></Reference><Reference><Citation>George P.M., Barratt S.L., Condliffe R., Desai S.R., Devaraj A., Forrest I. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75:1009&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghu G., Wilson K.C. COVID-19 Interstitial pneumonia monitoring the clinical course in survivors. Lancet Respir Med. 2020;8:839&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7398671</ArticleId><ArticleId IdType="pubmed">32758440</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-Rodr&#xed;guez J., Fern&#xe1;ndez-Velilla M., Ure&#xf1;a-Vacas A., Mart&#xed;n-Pinacho J.J., Rigual-Bobillo J.A., Jaurequ&#xed;zar-Oriol A., et al. Radiological management and follow-up of post-COVID-19 patients. Radiologia (Engl Ed) 2021;63:258&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015401</ArticleId><ArticleId IdType="pubmed">33726915</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz Almaz&#xe1;n M., Benedito P&#xe9;rez de Inestrosa T., Blasco Redondo R., Martinez del Valle M., Recio Garc&#xed;a S., Arnanz Gonz&#xe1;lez I., en representaci&#xf3;n de la Sociedad Espa&#xf1;ola de M&#xe9;dicos Generales y de Familia (SEMG) y colectivo Long COVID ACTS Experiencia del paciente afectado por COVID-19 persistente acerca de la utilidad y caracter&#xed;sticas de las escalas de valoraci&#xf3;n cl&#xed;nica de los s&#xed;ntomas derivados de su enfermedad. Med Gen Fam. 2021;10:69&#x2013;78.</Citation></Reference><Reference><Citation>Arnold DT, Milne A, Samms A, Stadon L, Maskell NA, Hamilton FW. Are vaccines safe in patients with Long COVID? A prospective observational study. [Accessed 23 December 2023]. Available from: https://www.medrxiv.org/content/10.1101/2021.03.11.21253225v310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253225v310</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>